Found: 86
Select item for more details and to access through your institution.
Psychopharmacologic Agents to Enhance Cognition in Alzheimer's Disease.
- Published in:
- Psychiatric Annals, 2015, v. 45, n. 7, p. 354, doi. 10.3928/00485713-20150626-07
- By:
- Publication type:
- Article
Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 11, p. 4414, doi. 10.1093/brain/awad188
- By:
- Publication type:
- Article
Generating real‐world evidence in Alzheimer's disease: Considerations for establishing a core dataset.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 4331, doi. 10.1002/alz.13785
- By:
- Publication type:
- Article
Translating AD Clinical Trial Results to Meaningful Benefits: Expectations, Definitions, Challenges and Opportunities.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.077766
- By:
- Publication type:
- Article
Estimating Treatment Effects of Disease‐modifying Drugs: Traditional Methods vs. Accelerated Failure Time Models and Progression Analysis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.071470
- By:
- Publication type:
- Article
Associations between neuropsychiatric symptoms, pathology in neuropathological cohorts of Alzheimer's disease, Alzheimer's disease with Lewy bodies and Dementia with Lewy bodies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079470
- By:
- Publication type:
- Article
Decline in cognitive trajectories in the neuropathological spectrum of Lewy Body disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079086
- By:
- Publication type:
- Article
Learning slopes in early‐onset Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S19, doi. 10.1002/alz.13159
- By:
- Publication type:
- Article
Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 4377, doi. 10.1002/alz.13357
- By:
- Publication type:
- Article
Expectations and clinical meaningfulness of randomized controlled trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2730, doi. 10.1002/alz.12959
- By:
- Publication type:
- Article
evoke and evoke+: design of two large‐scale, double‐blind, placebo‐controlled, phase 3 studies evaluating the neuroprotective effects of semaglutide in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.062415
- By:
- Publication type:
- Article
Unified Parkinson's Disease Rating Scale (UPDRS) motor score subscale trajectories in Dementia with Lewy Bodies and Parkinson Disease Dementia in a community autopsy cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1, doi. 10.1002/alz.066727
- By:
- Publication type:
- Article
Sex and APOE‐ε4 carrier effects on early‐onset Alzheimer's disease pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068743
- By:
- Publication type:
- Article
Investigating changes in fluid biomarkers in early Alzheimer's disease: design of plasma biomarker analyses and a cerebrospinal fluid sub‐study in the evoke and evoke+ trials of semaglutide versus placebo.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.062382
- By:
- Publication type:
- Article
Hemispheric asymmetry and atypical lobar progression of Alzheimer‐type tauopathy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.063208
- By:
- Publication type:
- Article
ICARE AD‐US: Design of a prospective, single‐arm, multicenter, noninterventional real‐world study of aducanumab in the United States.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057522
- By:
- Publication type:
- Article
Development and assessment of a brief screening tool for psychosis in dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057766
- By:
- Publication type:
- Article
Longitudinal motor decline in dementia with Lewy bodies and Parkinson's disease dementia in a community autopsy cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055838
- By:
- Publication type:
- Article
Ultrasound‐assisted lumbar puncture in Alzheimer's disease and related disorders research: A pilot study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056636
- By:
- Publication type:
- Article
P4‐374: DEPRESSIVE AND ANXIETY SYMPTOM VARIABILITY ATTENUATES MEMORY AND EXECUTIVE FUNCTION MEASURE DECLINE ESTIMATES IN COGNITIVELY UNIMPAIRED OLDER ADULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1443, doi. 10.1016/j.jalz.2019.06.4045
- By:
- Publication type:
- Article
P4‐288: DETAILS OF THE NEW ALZHEIMER'S ASSOCIATION BEST CLINICAL PRACTICE GUIDELINES FOR THE EVALUATION OF NEURODEGENERATIVE COGNITIVE BEHAVIORAL SYNDROMES, ALZHEIMER'S DISEASE AND DEMENTIAS IN THE UNITED STATES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1559, doi. 10.1016/j.jalz.2018.07.110
- By:
- Publication type:
- Article
P3‐003: IDENTIFYING ENRICHMENT FACTORS THAT PREDICT ALZHEIMER'S DISEASE PROGRESSION: AN ANALYSIS OF THREE RANDOMIZED, CONTROLLED TRIALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1062, doi. 10.1016/j.jalz.2018.06.1358
- By:
- Publication type:
- Article
Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0443-2
- By:
- Publication type:
- Article
Neuropsychological Test Performance and Cognitive Reserve in Healthy Aging and the Alzheimer's Disease Spectrum: A Theoretically Driven Factor Analysis.
- Published in:
- Journal of the International Neuropsychological Society, 2012, v. 18, n. 6, p. 1071, doi. 10.1017/S1355617712000859
- By:
- Publication type:
- Article
Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults.
- Published in:
- Human Brain Mapping, 2011, v. 32, n. 12, p. 2027, doi. 10.1002/hbm.21166
- By:
- Publication type:
- Article
Inter-Rater Reliability of Preprocessing EEG Data: Impact of Subjective Artifact Removal on Associative Memory Task ERP Results.
- Published in:
- Frontiers in Neuroscience, 2017, p. 1, doi. 10.3389/fnins.2017.00322
- By:
- Publication type:
- Article
MAINTENANCE OF COGNITIVE IMPROVEMENT TREATMENT RESPONSE WITH MEMANTINE AND DONEPEZIL: POST HOC ANALYSES FROM A PLACEBO-CONTROLLED STUDY IN PATIENTS WITH MODERATE TO SEVERE ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1232, doi. 10.1016/j.jalz.2017.07.430
- By:
- Publication type:
- Article
A QUANTITATIVELY-DERIVED SIB COMPOSITE MODEL IMPROVES DETECTION OF TREATMENT EFFECTS IN SEVERE ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1452, doi. 10.1016/j.jalz.2017.07.508
- By:
- Publication type:
- Article
IDALOPIRDINE, A 5-HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD-MODERATE ALZHEIMER’S DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1476, doi. 10.1016/j.jalz.2017.08.007
- By:
- Publication type:
- Article
IN THE CURRENT INFORMATION AGE, DO DEMENTIA CAREGIVERS GET THE INFORMATION THEY NEED? A QUALITATIVE STUDY OF INFORMAL CAREGIVERS’ EDUCATION SOURCES, BARRIERS, AND PREFERENCES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P595, doi. 10.1016/j.jalz.2016.06.1173
- By:
- Publication type:
- Article
IDALOPIRDINE, A 5-HT6 ANTAGONIST IN PHASE III DEVELOPMENT AS ADJUNCTIVE THERAPY TO CHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD-TO-MODERATE ALZHEIMER’S DISEASE: BASELINE DATA FROM THE ONGOING STARSHINE STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P423, doi. 10.1016/j.jalz.2016.06.803
- By:
- Publication type:
- Article
THE CHALLENGE OF IDENTIFYING AND ENGAGING INFORMAL CAREGIVERS IN THE ‘INTEGRATED CARE INITIATIVE’ (ICI): AN EDUCATION PROGRAM FOR CAREGIVERS OF PEOPLE WITH DEMENTIA OR COGNITIVE IMPAIRMENT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1122, doi. 10.1016/j.jalz.2016.06.2333
- By:
- Publication type:
- Article
Location, location, location: The distributed effects of amyloid on functional connectivity in the harvard aging brain study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P85, doi. 10.1016/j.jalz.2015.06.147
- By:
- Publication type:
- Article
Caregiver distress related to neuropsychiatric symptoms is reduced with extended-release memantine-cholinesterase inhibitor combination in patients with moderate to severe Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P749, doi. 10.1016/j.jalz.2015.06.1672
- By:
- Publication type:
- Article
Location, location, location: The distributed effects of amyloid on functional connectivity in the harvard aging brain study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P240, doi. 10.1016/j.jalz.2015.06.147
- By:
- Publication type:
- Article
Effectiveness of antidementia drugs in delaying Alzheimer's disease progression
- Published in:
- 2013
- By:
- Publication type:
- Editorial
A biomarker signal: Context-dependent hippocampal fMRI connectivity analysis of clinical trial measures in Alzheimer's disease
- Published in:
- 2012
- By:
- Publication type:
- Abstract
A biomarker signal: Context-dependent hippocampal fMRI connectivity analysis of clinical trial measures in Alzheimer's disease
- Published in:
- 2012
- By:
- Publication type:
- Abstract
fMRI Context-dependent connectivity in Alzheimer's disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Presence of extrapyramidal motor signs predict worse cognitive and functional trajectory of decline in mild-to-moderate Alzheimer's
- Published in:
- 2010
- By:
- Publication type:
- Abstract
A candidate fMRI measure combining hipppocampal and default mode network activity to predict future memory performance in Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Optimizing FMRI test-retest reliability and power estimates for Alzheimer's disease early-phase studies: Modeling decline and leveraging network properties
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Optimizing fmri test-retest reliability and power estimates for alzheimer's disease early-phase studies: Modeling decline and leveraging network properties
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P1-219: Feasibility and test-retest reliability of fMRI in an Alzheimer's disease clinical trial
- Published in:
- 2008
- By:
- Publication type:
- Abstract
IC-P2-073: Feasibility and test-retest reliability of fMRI in an Alzheimer's disease clinical trial
- Published in:
- 2008
- By:
- Publication type:
- Abstract
IC-P-105: Longitudinal change in fMRI activation correlates with change in clinical trial measures in Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
IC-101-05: fMRI alterations in medial temporal and default mode activity in MCI and AD
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-408: Early real-world clinical experience with memantine treatment for Alzheimer’s disease in the United States
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P2-326: Longitudinal change in FMRI activation correlates with change in clinical trial measures in Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P2-302: FMRI alterations medial temporal and neocortical networks in MCI and AD
- Published in:
- 2006
- By:
- Publication type:
- Abstract